Oculogica, Inc. — Form D
Oculogica, Inc. of New Richmond, WI, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-13. The offering totals $18.0M, of which $7.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-13
- Form: D
- Accession: 0001613810-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $7.6M
- Remaining: $10.4M
- Investors: 24
- Date of first sale: 2024-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513105
Issuer
- Name: Oculogica, Inc.
- CIK: 0001613810
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1477 S. Knowles Ave. #110F, New Richmond, WI, 54017
- Phone: 484-393-2694
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jill Enos | Director | New Richmond, WI |
| Jim Flannigan | Director | New Richmond, WI |
| Pratipatti Laxminarain | Director | New Richmond, WI |
| Rosina Samadani | Director | New Richmond, WI |
| Uzma Samadani | Director | New Richmond, WI |
| Kathryn Swintek | Director | New Richmond, WI |
| Rosina Samadani | Executive Officer | New Richmond, WI |
| Bilal Khan | Director | New York, NY |
| Jason Huang | Director | Huntington Beach, CA |
| Robert Ritlop | Executive Officer | New York, NY |
Other filings by this issuer (4)
More